Production Lines Overview
ODF
(Oral Disintegrating Films)
Edge Pharma’s Oral Disintegrating Films (ODF) production line represents a leap forward in patient-centric drug delivery. This cutting-edge technology offers a unique solution for individuals who struggle with traditional tablets or capsules, providing a rapid, efficient, and convenient way to administer medications. Our ODF production line integrates advanced equipment and automation to create high-quality, fast-dissolving films that ensure precise dosage and immediate therapeutic effect. Manufactured under the highest standards of cGMP, WHO, and FDA guidelines, this line offers: – Precision formulation: Each film is engineered to dissolve quickly on the tongue, providing swift absorption of the active pharmaceutical ingredients (APIs), ensuring fast onset of action for effective therapeutic results. – Enhanced bioavailability: The unique design of ODF technology allows for better absorption and bioavailability compared to traditional oral dosage forms, making it ideal for patients with swallowing difficulties or those who require rapid relief. – Advanced manufacturing equipment: The line is equipped with automated film-casting machines, precision cutting systems, and real-time in-line monitoring to ensure uniform thickness and consistency in every batch. – Customized dosage forms: Whether for over-the-counter products or prescription medications, we can customize the formulation to meet specific patient needs, from pain relief to anti-allergies, with options for various active ingredients. By focusing on both patient convenience and effective drug delivery, the ODF line at Edge Pharma represents our dedication to improving patient compliance and overall treatment success. Our “Beyond what you can reach” philosophy is reflected in the creation of innovative dosage forms like ODF that break the barriers of traditional medication administration and enhance therapeutic outcomes.
SVP
(Small Volume Parenterals)
At Edge Pharma, our Small Volume Parenterals (SVP) production line is a cornerstone of our sterile manufacturing operations — designed with uncompromising precision to deliver injectable therapies that are safe, effective, and aligned with international regulatory standards. Built in accordance with WHO, FDA, and cGMP guidelines, the SVP line is fully equipped to handle a wide spectrum of sterile liquid formats, including: – Prefilled syringes: Offering ready-to-use solutions with enhanced sterility assurance and reduced dosing errors. Ideal for emergency care, vaccination programs, and self-administered treatments. – Single-dose eye drops: Formulated with delicate actives and filled in sterile, preservative-free units for ophthalmic safety and therapeutic purity. – Multi-dose eye drops: Produced with antimicrobial agents and precision dropper assemblies to ensure multi-use safety while maintaining product integrity. – Injection ampoules: Manufactured in a cleanroom environment with high-speed ampoule washing, filling, and sealing technology, ensuring sterility and breakage resistance. – Sterile vials: Available in a range of volumes and closures, suitable for both aqueous and oil-based formulations, supported by validated terminal sterilization processes. Each product on the SVP line is subject to stringent in-process controls, automated inspection systems, and real-time environmental monitoring, ensuring consistent quality and regulatory compliance. The line also features fully automated filling, stoppering, and capping units, integrated with advanced particle and microbial control systems. At Edge Pharma, our SVP line reflects more than just technological capability — it embodies our mission to deliver safe, sterile, and accessible injectable solutions that exceed expectations. With every drop, ampoule, or vial, we go “Beyond what you can reach” — bringing precision, safety, and innovation to the heart of modern injectable medicine.
LVP
(Large Volume Parenterals)
At Edge Pharma, the Large Volume Parenterals (LVP) production line is designed to meet the most critical demands of modern healthcare — delivering sterile, high-volume infusion solutions with unmatched reliability and safety. Our LVP line is built to align with global WHO, FDA, and cGMP standards and operates in a fully controlled cleanroom environment, ensuring sterility across every phase of production. The line is equipped to manufacture a wide range of essential intravenous solutions, including: – Standard infusion fluids such as Sodium Chloride, Dextrose, and Ringer’s Lactate. – Analgesics for pain management. – Antibiotic infusions for broad and targeted antimicrobial therapy. – Amino acid-based solutions for clinical nutrition and recovery support. Packaging formats include: – PE (Polyethylene) containers, ideal for cost-effective, safe delivery. – PP (Polypropylene) containers, specially designed for high-temperature autoclave sterilization at 121°C, providing superior microbial integrity and extended shelf life. The entire production process is managed through automated mixing, filling, and sealing systems, supported by: – In-line sterilization and filtration technologies. – Terminal sterilization in high-capacity autoclaves. – Real-time environmental and quality control monitoring. With this line, Edge Pharma guarantees 100% sterility assurance and consistent batch-to-batch performance, making our LVP solutions suitable for use in ICUs, emergency departments, operating rooms, and inpatient care. Through every bottle we produce, we reaffirm our commitment to therapeutic safety, clinical precision, and advanced pharmaceutical care — going “Beyond what you can reach” to serve the critical needs of modern medicine.
BOV
(Bag-on-Valve Technology)
At Edge Pharma, the Bag-on-Valve (BOV) production line represents a new era in pharmaceutical delivery systems — combining patient convenience, product stability, and environmental safety in a single, cutting-edge solution. BOV technology is designed for sterile, preservative-free formulations that require pressurized, controlled dispensing, making it ideal for: – Nasal sprays – Topical dermatological products – Wound care solutions – Sterile saline irrigation – Inhalation and respiratory therapies What sets our BOV line apart: – Aseptic separation between the formulation and the propellant, ensuring product purity and extended shelf life. – 360-degree usability, allowing dispensing in any orientation — even upside down. – Minimal contamination risk, as the product is sealed within a collapsible bag inside the canister, completely isolated from external air and contact. – Preservative-free solutions, improving patient safety and reducing the risk of irritation or allergic reactions. Our BOV production line includes: – Automated cleaning, sterilization, and assembly of the bag-valve system. – Precision filling and sealing under sterile conditions. – In-line leak detection, pressure testing, and weight verification. – Full compliance with cGMP, FDA, and WHO standards. This line is especially beneficial for sensitive patient groups such as pediatrics, geriatrics, and those with chronic conditions — delivering consistent doses with superior hygiene and user-friendly handling. Through our BOV technology, Edge Pharma continues to push the boundaries of pharmaceutical innovation — ensuring drug delivery systems are not only effective, but intuitive, clean, and aligned with the modern patient’s lifestyle. With BOV, we go “Beyond what you can reach” — by placing control, comfort, and confidence directly in the patient’s hands.
Solid Dosage Forms
The Solid Dosage Forms production line at Edge Pharma is a symbol of pharmaceutical precision, scalability, and therapeutic consistency. Designed to meet the growing demand for reliable oral treatments, this line combines cutting-edge manufacturing technology with stringent quality control systems — ensuring every dose delivers its intended effect safely and efficiently. Our facility produces a wide range of solid oral medications including: – Tablets (coated, uncoated, chewable, and modified release) – Hard gelatin capsules – Effervescent and dispersible tablets Key features of the line include: – High-capacity granulation systems (wet and dry) for optimal powder blending and flowability. – State-of-the-art compression machines capable of producing high-speed, high-volume tablet batches with precise weight and hardness. – Automated capsule filling lines with full in-line weight verification and sorting. – Advanced coating systems for enteric protection, taste masking, and controlled drug release. – Inline PAT (Process Analytical Technology) tools for real-time quality monitoring during critical processing stages. The line operates under full compliance with WHO, FDA, and cGMP regulations, with segregated air-handling units and environmental controls that prevent cross-contamination and maintain batch integrity. Through this line, Edge Pharma delivers high-quality oral medications that combine patient convenience, therapeutic efficacy, and manufacturing excellence — ensuring a consistent experience from the first dose to the last. Whether for chronic care, acute treatment, or preventive therapies, our solid dosage solutions embody our commitment to innovation and reliability — taking pharmaceutical care “Beyond what you can reach”.
Sime Solid Dosage Forms
At Edge Pharma, our Sime Solid Dosage Forms production line is crafted to deliver top-quality dermatological and mucosal therapies, combining pharmaceutical precision with patient comfort and usability. This line supports the development and manufacturing of a wide spectrum of topical, transdermal, and rectal preparations, ensuring targeted, localized therapeutic action. Product categories include: – Creams – both oil-in-water (O/W) and water-in-oil (W/O) emulsions for various skin conditions. – Ointments – for deep skin penetration and long-lasting effects. – Gels – non-greasy, fast-absorbing formulas for rapid action and cooling relief. – Suppositories – rectal and vaginal forms for localized treatment with systemic impact. Technological features of the line: – Precision mixing and homogenization units to ensure uniform API distribution and optimal consistency. – Vacuum processing vessels for air-free, contamination-resistant preparation. – Automatic filling and sealing machines with volume accuracy and high-speed output for tubes, jars, and suppository molds. – Climate-controlled cleanrooms, built to meet strict cGMP, FDA, and WHO guidelines — ensuring microbial control and product safety. The line also integrates in-process analytical monitoring, stability testing, and microbial quality assurance, all aimed at delivering consistent texture, absorption rate, and therapeutic performance across every unit produced. By advancing in semisolid formulations, Edge Pharma offers modern solutions for conditions where systemic therapies are less effective or unnecessary — maximizing local treatment benefits with minimum side effects. With every cream, ointment, gel, or suppository we produce, we reaffirm our promise to care, innovate, and deliver excellence — going “Beyond what you can reach” in the world of topical and localized treatments.
